Secretion of insulin-like growth factors and their binding proteins by human normal and hyperplastic prostatic cells in primary culture

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 2, 1996, Pages 612-617

  Boudon, C ^a   Rodier, G ^a   Lechevallier, E ^b   Mottet, N ^c   Barenton, B ^d   Sultan, Ch ^a,e  

^a LAPEYRONIE HOSPITAL   (France)

^b Child and Adolescent Psychopathology Unit Salvator Hospital Public Assistance Marseille Hospitals University Aix Marseille II   (France)

^c Polyclinique Kennedy   (France)

^d CEMAGREF   (France)

^e INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; GROWTH REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATE SECRETION;

CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 4; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MALE; PROSTATE; PROSTATIC HYPERPLASIA;

EID: 0030062101     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.2.612     Document Type: Article

References (29)

1. McNeal JE. 1988 Normal histology of the prostate. Am J Surg Pathol. 12:619-633.
2. Bonnet P, Reiter E, Bruyninx M, et al. 1993 Benign prostatic hyperplasia and normal prostate aging: differences in types I and II 5α-reductase and steroid hormone receptor messenger ribonucleic acid (mRNA) levels, but not in insulin-like growth factor mRNA levels. J Clin Endocrinol Metab. 77:1203-1208.
3. McNeal JE. 1978 Origin and evolution of benign prostatic enlargement. Invest Urol. 15:340-345.
4. Cunha GR, Donjacour AA, Cooke PS, et al. 1987 The endocrinology and developmental biology of the prostate. Endocr Rev. 8:338-362.
5. McNeal J. 1984 Anatomy of the prostate and morphogenesis of BPH. In: Kimball F, Buhl A, Carter D, eds. News approaches to the study of BPH. New York: Liss; 307-332.
6. Fiorelli G, De Bellis A, Longo A, et al. 1991 Growth factors in the human prostate. J Steroid Biochem Mol Biol. 40:199-205.
7. Fiorelli G, De Bellis A, Longo A, et al. 1991 Insulin-like growth factor-I receptors in human hyperplastic prostate tissue: characterization, tissue localization, and their modulation by chronic treatment with a gonadotropin-releasing hormone analog. J Clin Endocrinol Metab. 72:740-746.
8. Elgin RG, Busby WHJ, Clemmons DR. 1987 An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I. Proc Natl Acad Sci USA. 84:3254-3258.
9. Rosenfeld RG, Lamson G, Pham H, et al. 1990 Insulin like growth factor-binding proteins. Recent Prog Horm Res. 46:99-163.
10. Webber MM. 1979 Normal and benign human prostatic epithelium in culture. In Vitro. 15:967-982.
11. Peehl D, Stamey T. 1984 Serial propagation of adult human prostatic epithelial cells with cholera toxin. In Vitro. 20:981-986.
12. Mohan S, Bautista CM, Herring S J, Linkhart TA, Baylink DJ. 1990 Development of valid methods to measure insulin-like growth factor I and factor II in bone cell conditioned medium. Endocrinology. 126:2534-2542.
13. Barenton B, Guyda HJ, Goodyer CG, Polychronakos C, Posner BI. 1987 Specificity of insulin-like growth factor binding to type-II IGF receptors in rabbit mammary gland and hypophysectomized rat liver. Biochem Biophys Res Commun. 149:555-561.
14. Blanchard MM, Goodyer CG, Charrier J, Barenton B. 1988 In vitro regulation of growth hormone (GH) release from ovine pituitary cells during fetal and neonatal development: effects of GH-releasing factor, somatostatin, and insulin-like growth factor I. Endocrinology. 122:2114-2120.
15. Hossenlopp P, Binoux M. 1994 Use of peptide ligands for the detection of binding proteins by western ligand blotting. In: Dunbar BS, eds. Protein blotting, a practical approach. Oxford: Oxford University Press; 169-186.
16. Cohen P, Peehl DM, Lamson G, Rosenfeld RG. 1991 Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins in primary cultures of prostate epithelial cells. J Clin Endocrinol Metab. 73:401-407.
17. Barni T, Vannelli BG, Sadri R, et al. 1994 Insulin-like growth factor-I (IGF-I) and its binding protein IGF-BP4 in human prostatic hyperplastic tissue: gene expression and its cellular localization. J Clin Endocrinol Metab. 78:778-783.
18. Perkel VS, Mohan S, Baylink DJ, Linkhart TA. 1990 An inhibitory insulin-like growth factor binding protein (IN-IGFBP) from human prostatic cell conditioned medium reveals N-terminal sequence identity with bone derived IN-IGFBP. J Clin Endocrinol Metab. 71:533-535.
19. Cohen P, Graves HCB, Peehl DM, Kamarei M, Giudice LC, Rosenfeld RG. 1992 Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J Clin Endocrinol Metab. 75: 1046-1053.
20. Hernandez ER, Roberts JCT, LeRoith D, Adashi EY. 1989 Rat ovarian insulin-like growth factor-I (IGF-I) gene expression is granulosa cell-selective: 5′-untranslated region mRNA variant representation and hormonal regulation. Endocrinology. 125:572-574.
21. Yee D, Paik S, Lebovic GS, al e. 1986 Analysis of insulin-like growth factor I gene expression in human breast cancer. Mol Endocrinol. 3:509-517.
22. Hernandez ER, Hurwitz A, Vera A, et al. 1992 Expression of the genes encoding the insulin-like growths (actors and theirs receptors in the human ovary. J Clin Endocrinol Metab. 74:419-425.
23. Daughaday WH, Rotwein P. 1989 Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev. 10:68-91.
24. Cohen P, Peehl DM, Baker B, Liu F, Hintz RL, Rosenfeld RG. 1994 Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia. J Clin Endocrinol Metab. 79:1410-1415.
25. Birnbaum RS, Ware JL, Plymate RS. 1994 Insulin-like growth factor binding protein-3 expression and secretion by cultures of human prostate epithelial cells and stromal fibroblasts. J Endocrinol. 141:535-540.
26. Kaicer E, Blat C, Imbenotte J, et al. 1993 IGF binding protein-3 secreted by the prostate adenocarcinoma cells (PC-3): differential effect on PC-3 and normal prostate cell growth. Growth Regul. 3:180-189.
27. Lee KO, Oh YM, Giudice LC, Cohen P, Peehl DM, Rosenfeld RG. 1994 Identification of insulin-like growth factor-binding protein-3 (IGFBP-3) fragments and IGFBP-5 proteolytic activity in human seminal plasma: a comparison of normal and vasectomized patients. J Clin Endocrinol Metab. 79:1367-1372.
28. Conover CA, Perry JE, Mulvihill CF, Tindall D. Endogenous cathepsin D-mediated hydrolysis of insulin-like growth factor binding proteins in cultured human prostatic carcinoma cells [Abstract 1052]. Proc of the 76th Annual Meet of The Endocrine Soc. 1994.
29. Jones J, Clemmons D. 1995 Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev. 16:3-34.